Exuma Biotechnology
Phase 1EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
Founded
2015
Focus
Cell & Gene Therapy
About
EXUMA Biotech is a clinical-stage biotech company advancing gene vector delivery to enhance patient access to innovative cell and gene therapies.
Funding History
2Total raised: $150M
Series B$100MUndisclosedFeb 15, 2023
Series A$50MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2015
LocationCoral Gables, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile